Chinese journal of natural medicinesAnimalsLiver NeoplasmsHumansCarcinomaHepatocellular
Bisdemethoxycurcumin suppresses liver fibrosis-associated hepatocellular carcinoma via inhibiting CXCL12-induced macrophage polarization.
Wei Yuan, Xinxin Zeng, Bin Chen, Sihan Yin, Jing Peng, Xiong Wang, Xingxing Yuan, Kewei Sun
Published: 202510.1016/S1875-5364(25)60871-5
Abstract
Chronic, unresolved inflammation correlates with persistent hepatic injury and fibrosis, ultimately progressing to hepatocellular carcinoma (HCC). Bisdemethoxycurcumin (BDMC) demonstrates therapeutic potential against HCC, yet its mechanism in preven…
Preview only. Read the full abstract at the source